Keyphrases
Clinical Factors
100%
Chronic Dialysis
100%
Prasugrel
100%
P2Y12 Inhibitors
100%
Ticagrelor
77%
Clopidogrel
77%
Adjusted Odds Ratio
44%
End-stage Renal Disease Patients
44%
Dialysis
22%
Peritoneal Dialysis
22%
Hispanic
11%
Non-associated
11%
Underutilization
11%
African American
11%
Comorbidity
11%
Patient Demographics
11%
Anticoagulant Use
11%
Hemodialysis
11%
Comparative Effectiveness Studies
11%
Atrial Fibrillation
11%
Drug-eluting
11%
Maintenance Hemodialysis Patients
11%
Informed Decision-making
11%
End-stage Renal Disease
11%
ST-elevation Myocardial Infarction (STEMI)
11%
Percutaneous Coronary Intervention
11%
Prescribing Practices
11%
Trend Factors
11%
Perceived Complexity
11%
P2Y12
11%
United States Renal Data System (USRDS)
11%
Prescribing Trends
11%
Coronary Stent
11%
Approved Indication
11%
Oral Anticoagulants
11%
Neuroscience
P2Y12
100%
Prasugrel
100%
Ticagrelor
77%
Clopidogrel
77%
Antithrombotic
11%
Comorbidity
11%
Myocardial Infarction
11%
Atrial Fibrillation
11%
Pharmacology, Toxicology and Pharmaceutical Science
Prasugrel
100%
Ticagrelor
77%
Clopidogrel
77%
End Stage Renal Disease
55%
Hemodialysis
22%
Anticoagulant Agent
11%
Atrial Fibrillation
11%
Effectiveness Study
11%
Non ST Segment Elevation Myocardial Infarction
11%
Comorbidity
11%
Biochemistry, Genetics and Molecular Biology
Prasugrel
100%
P2Y12
100%
Clopidogrel
77%
Hemodialysis
22%
Peritoneal Dialysis
22%
Population
11%
ST Elevation
11%
Effectiveness Study
11%
Comorbidity
11%
Atrial Fibrillation
11%